BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · IEX Real-Time Price · USD
0.790
+0.030 (3.95%)
At close: Jul 19, 2024, 4:00 PM
0.781
-0.010 (-1.20%)
Pre-market: Jul 22, 2024, 7:35 AM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $14.44 million as of July 22, 2024. Its market cap has decreased by -85.44% in one year.
Market Cap
14.44M
Enterprise Value
13.51M
1-Year Change
-85.44%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $14.44M, a decrease of -44.44%. That is a compound annual growth rate of -15.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 14.40M | -84.60% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centogene | 15.07M |
| Immuron | 15.05M |
| Talphera | 14.78M |
| Star Equity Holdings | 14.64M |
| Evaxion Biotech | 14.60M |
| Flora Growth | 14.44M |
| XTL Biopharmaceuticals | 14.00M |
| Kintara Therapeutics | 13.94M |